

Dopamine(DOPE) Price Live Chart
Dopamine(DOPE) price today is $0.001238, with a 24-hour trading volume of $87.65K and as such Dopamine(DOPE) has a market cap of $33.7K, giving it a market dominance of 0.0000044%. The Dopamine(DOPE) price moved -1.90% in the last 24 hours.
DOPE Price Data
- 24H Volume$87.65K
- All-Time High(ATH)$0.6559
- 24h High$0.001294
- All-Time Low(ATL)$0.0005
- 24h Low$0.001103
DOPE Market Cap Infos
- Market Cap$33.7K
- Fully Diluted Valuation$154.82K
- Market Cap/FDV21.77%
- Market SentimentPositive
DOPE Supply
- Circulating Supply27.2M DOPE
- Total Supply125M DOPE
- Max Supply125M DOPE
Dopamine(DOPE) is predicted to average $0.001238 in 2025, with a potential swing between the lowest price $0.0006686 and the highest price $0.001845. By 2035, Dopamine(DOPE) price could reach to $0.007006, offering a potential +290.00% return from today’s Dopamine price.
Year | Minimum Price | Highest Price | Average Price | Change |
---|---|---|---|---|
2025 | $0.0006686 | $0.001845 | $0.001238 | -- |
2026 | $0.001495 | $0.002065 | $0.001541 | +24.00% |
2027 | $0.00119 | $0.00229 | $0.001803 | +45.00% |
2028 | $0.001166 | $0.002395 | $0.002047 | +65.00% |
2029 | $0.001243 | $0.00251 | $0.002221 | +79.00% |
2030 | $0.001443 | $0.003217 | $0.002365 | +90.00% |
2031 | $0.002428 | $0.003377 | $0.002791 | +125.00% |
2032 | $0.00219 | $0.00441 | $0.003084 | +149.00% |
2033 | $0.003073 | $0.005284 | $0.003747 | +202.00% |
2034 | $0.003432 | $0.005148 | $0.004516 | +264.00% |
2035 | $0.00343 | $0.007006 | $0.004832 | +290.00% |
Dopamine(DOPE) price has moved -1.90% in the last 24 hours, and -1.78% in the past 7 days. The price of Dopamine(DOPE) is -7.60% in the past 30 days, and -93.12%over the last year.
Time period | Change amount | % Change |
---|---|---|
1H | +$0.0000002476 | +0.02% |
24H | -$0.00002398 | -1.90% |
7D | -$0.00002244 | -1.78% |
30D | -$0.0001018 | -7.60% |
1Y | -$0.01676 | -93.12% |
About Dopamine (DOPE)
Contract

8kqmghm1m...d3eanwkcd
Explorers
explorer.solana.com
Website
web3intelligence.com
Dopamine (DOPE) Investors


